Performance-Based Risk-Sharing Arrangements: An Updated International Review

被引:0
|
作者
Josh J. Carlson
Shuxian Chen
Louis P. Garrison
机构
[1] University of Washington,Pharmaceutical Outcomes Research and Policy Program
来源
PharmacoEconomics | 2017年 / 35卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Enthusiasm for performance-based risk-sharing arrangements (PBRSAs) continues but at variable pace across countries. Our objective was to identify and characterize publicly available cases and related trends for these arrangements. We performed a review of PBRSAs from 1993 to 2016 using the University of Washington PBRSA Database. Arrangements were categorized according to a previously published taxonomy. Macro-level trends were identified related to the timing of adoption, countries involved, types of arrangements, and disease areas. Our search yielded 437 arrangements. Among these, 183 (41.9%) were categorized as currently active, while 58.1% have expired. Five main types of arrangements have been identified, namely coverage with evidence development (149 cases, 34.1%), performance-linked reimbursement (104 cases, 23.8%), conditional treatment continuation (78 cases, 17.8%), financial or utilization (71 cases, 16.2%), and hybrid schemes with multiple components (35 cases, 8.0%). The pace of adoption varies across countries but has renewed an upward trend after a lull in 2012/2013. Conditions in the USA may be changing toward a more favorable environment of PBRSAs. Interest in PBRSAs remains high, suggesting they are a viable coverage and reimbursement mechanism for a wide range of medical products.
引用
收藏
页码:1063 / 1072
页数:9
相关论文
共 50 条
  • [31] A wavelet analysis of international risk-sharing
    Trezzi, Riccardo
    [J]. ECONOMICS LETTERS, 2013, 118 (02) : 330 - 333
  • [32] INTERNATIONAL RISK-SHARING AND NONTRADED GOODS
    TESAR, LL
    [J]. JOURNAL OF INTERNATIONAL ECONOMICS, 1993, 35 (1-2) : 69 - 89
  • [33] PAY-FOR-PERFORMANCE RISK-SHARING ARRANGEMENTS FOR MEDICAL TECHNOLOGY IN CHINA: APPLICATION AND PROSPECT
    Ai, Y.
    Wang, J.
    Zhao, J.
    Ming, J.
    Liu, J.
    Hu, M.
    Chen, Y.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S302 - S302
  • [34] The risk-sharing implications of alternative social security arrangements - A comment
    Imrohoroglu, S
    [J]. CARNEGIE-ROCHESTER CONFERENCE SERIES ON PUBLIC POLICY, VOL 50, JUNE 1999, 1999, 50 : 261 - 269
  • [35] Traditional risk-sharing arrangements and informal social insurance in Eritrea
    Habtom, GebreMichael Kibreab
    Ruys, Pieter
    [J]. HEALTH POLICY, 2007, 80 (01) : 218 - 235
  • [36] International risk-sharing and lessons for EMU - A comment
    Bayoumi, T
    [J]. CARNEGIE-ROCHESTER CONFERENCE SERIES ON PUBLIC POLICY, VOL 51, DECEMBER 1999, 1999, 51 : 189 - 193
  • [37] The Impact of Firm Heterogeneity on International Risk-Sharing
    Chang, Ming-Jen
    Chen, Shikuan
    Wu, Yen-Chen
    [J]. CESIFO ECONOMIC STUDIES, 2024,
  • [38] ROLE OF CLINICAL PHARMACIST IN OPTIMIZING REIMBURSEMENT ORIGINATING FROM PERFORMANCE-BASED RISK-SHARING ARRANGEMENTS: THE EXPERIENCE OF THE UNIVERSITY HOSPITAL "G. MARTINO" FROM MESSINA, ITALY
    Polimeni, G.
    Isgro, V
    Aiello, A.
    D'Ausilio, A.
    D'Addetta
    Cuzzocrea, S.
    Caputi, A. P.
    Toumi, M.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A756 - A756
  • [39] Interregional and international risk-sharing and lessons for EMU
    Mélitz, J
    Zumer, F
    [J]. CARNEGIE-ROCHESTER CONFERENCE SERIES ON PUBLIC POLICY, VOL 51, DECEMBER 1999, 1999, 51 : 149 - 188
  • [40] Economic Impact of Coverage Expansion for Non-invasive Prenatal Testing Through a Performance-Based Risk-Sharing Agreement
    Quinlan, Taryn A. G.
    Schroeder, Brock
    Kwon, Sue
    Barlow, Jane F.
    Sherman, Michael S.
    Anderson, Heather D.
    Wright, Garth
    McQueen, R. Brett
    [J]. PHARMACOECONOMICS-OPEN, 2021, 5 (03) : 449 - 458